CrystalGenomics Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW92.33 |
Market Cap |
KRW887.53 B |
Shares Outstanding |
39.62 M |
Public Float |
32.01 M |
Address |
5/F, Tower A, Korea Bio Park Seongnam GY 13488 Korea, Republic Of |
Employees | - |
Website | http://www.crystalgenomics.com |
Updated | 09/14/2018 |
CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company operates through following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services. |